AstraZeneca admits people may have rare side effects from Covishield vaccine
AstraZeneca is facing several lawsuits in Britain over claims that its vaccine has caused several deaths and serious injuries. In 51 cases in the UK High Court, victims are demanding damages of up to 100 million pounds.
AstraZeneca, the company making the anti-Covid-19 vaccine 'Covishield', has itself admitted that rare side effects may occur in people taking it. According to the report the British pharma giant AstraZeneca has admitted that its Covid vaccine may have rare side effects. The vaccine manufacturer has said in court documents that Covishield, in rare cases, can cause a condition that can lead to blood clots and low platelet counts.
Covishield, developed by AstraZeneca and Oxford University, was produced by the Serum Institute of India during the pandemic and was widely administered to people in the country. AstraZeneca is facing several lawsuits in Britain over claims that its vaccine has caused several deaths and serious injuries. In 51 cases in the UK High Court, victims are demanding damages of up to 100 million pounds.
Jamie Scott, the first complainant in the case, had alleged that he was given the vaccine in April 2021, which caused permanent brain injury after blood clotting. He claimed that it made it difficult for him to work... The hospital even told his wife three times that he was going to die.
AstraZeneca has disputed the claims, but acknowledged in a court document in February that Covishield "can, in very rare cases, cause TTS," the report said. TTS (Thrombosis with Thrombocytopenia Syndrome) causes blood clots and low blood platelet counts in humans.
"It is believed that the AZ vaccine may, in very rare cases, cause TTS. Additionally, TTS may occur in the absence of the AZ vaccine (or any vaccine)," AstraZeneca said. AstraZeneca agreed to the legal defense of Scott's claim, which could lead to payments to victims and bereaved relatives.
The latest admission also contradicts the company's 2023 stance, in which it told Jamie Scott's lawyers: "We do not accept that TTS is caused by the vaccine on a moderate scale." However, AstraZeneca has denied lawyers' claims that the vaccine is "defective" and that its efficacy has been "grossly overstated".